Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 PK comparability of single vs multiple capsules of Orforglipron in healthy participants
jRCT2051240196Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of orforglipron, sponsored by Eli Lilly and Company. Primary endpoint: Steady-state AUC of Orforglipron (fasted state). Started Dec 2024; status: completed.
02
Drugs
orforglipron
Beyond the preview
Go deeper on jRCT2051240196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051240196.